Obstructive Sleep Apnea Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Obstructive Sleep Apnea stocks.

Obstructive Sleep Apnea Stocks Recent News

Date Stock Title
Oct 1 TEVA Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
Oct 1 RMD RMD Stock Likely to Gain From Enhanced Digital Sleep Health Solutions
Oct 1 TEVA Teva Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.
Oct 1 TEVA Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?
Oct 1 SPRC Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
Sep 30 RMD ResMed '2030 Strategy' aims for high-single-digit revenue growth.
Sep 30 TEVA Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024
Sep 30 RMD ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
Sep 30 TEVA $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today
Sep 30 TEVA Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ...
Sep 30 RMD UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
Sep 30 RMD UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
Sep 30 RMD ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
Sep 30 RMD ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
Sep 30 RMD Is ResMed Inc.'s (NYSE:RMD) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Sep 28 TEVA Here are the Medicare Part D drugs expected to face 2025 price negotiations
Sep 27 NYXH DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Sep 27 TEVA Amazon to provide opioid overdose drug in workplace
Sep 27 INSP This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
Sep 27 NYXH Publication relating to transparency notifications
Obstructive Sleep Apnea

Obstructive sleep apnea (OSA) is the most common type of sleep apnea and is caused by complete or partial obstructions of the upper airway. It is characterized by repetitive episodes of shallow or paused breathing during sleep, despite the effort to breathe, and is usually associated with a reduction in blood oxygen saturation. These episodes of decreased breathing, called "apneas" (literally, "without breath"), typically last 20 to 40 seconds.Individuals with OSA are rarely aware of difficulty breathing, even upon awakening. It is often recognized as a problem by others who observe the individual during episodes or is suspected because of its effects on the body. OSA is commonly accompanied with snoring. Some use the terms obstructive sleep apnea syndrome or obstructive sleep apnea–hypopnea syndrome to refer to OSA which is associated with symptoms during the daytime. Symptoms may be present for years or even decades without identification, during which time the individual may become conditioned to the daytime sleepiness and fatigue associated with significant levels of sleep disturbance. Individuals who generally sleep alone are often unaware of the condition, without a regular bed-partner to notice and make them aware of their symptoms.
As the muscle tone of the body ordinarily relaxes during sleep, and the airway at the throat is composed of walls of soft tissue, which can collapse, it is not surprising that breathing can be obstructed during sleep. Although a minor degree of OSA is considered to be within the bounds of normal sleep, and many individuals experience episodes of OSA at some point in life, a small percentage of people have chronic, severe OSA.
Many people experience episodes of OSA for only a short period. This can be the result of an upper respiratory infection that causes nasal congestion, along with swelling of the throat, or tonsillitis that temporarily produces very enlarged tonsils. The Epstein-Barr virus, for example, is known to be able to dramatically increase the size of lymphoid tissue during acute infection, and OSA is fairly common in acute cases of severe infectious mononucleosis. Temporary spells of OSA syndrome may also occur in individuals who are under the influence of a drug (such as alcohol) that may relax their body tone excessively and interfere with normal arousal from sleep mechanisms.

Browse All Tags